Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
   
Ask the Experts About

Opportunistic InfectionsOpportunistic Infections
           
Rollover images to visit our other forums!
  
  • Email Email
  • Glossary Glossary


Pneumocystis carinii pneumonia
Jun 23, 1999

What are some of the latest developments in preventing and treating this infection?

Response from Dr. Currier

THe best prevention is for people who have T cells below 200 cells to take trimethprim-sulfamethoxazole (bactrim) either daily or 3 times per week. For those allergic to sulfa, either dapsone, aerosolozed pentamidine or atovaquone(mepron) can be substituted. If the sulfa allergy was not anaphylaxis, desensitization can allow the drug to be used for some people. None of this is terribly new, but it remains very important. For treatment the drug of choice remains trimethoprim-sulfa, with other options for sulfa allergic patients that include trimethoprim-dapsone, clindamycin+primaquine, atovaquone or pentamidine , the choice of agent depends to some degree on the severity of the case. Hope this helps.

-JC


Previous
PCP Prophylaxis
Next
treatment of pcp

  
  • Email Email
  • Glossary Glossary


 
 
Advertisement




Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement